Periodic Reporting for period 2 - VPH-CaSE (VPH-Cardiovascular Simulation and Experimentation for Personalised Medical Devices)

Cardiovascular disease accounts for 47% of deaths in Europe with an estimated cost to the EU of ~ €196 billion a year. Use of simulation to optimise medical device design for patient-specific treatment offers benefits and is being championed in Europe through the Virtual...